Impact of Pharmaceutical Impurities in Ecstasy Tablets: Gas Chromatography-Mass Spectrometry Study

AuthorAmir Jalalien
AuthorAmir Hatamieen
AuthorTahere Saferpouren
AuthorAlireza Khajeamirien
AuthorTahere Safaen
AuthorFoad Buazaren
Issued Date2016-01-31en
AbstractIn this study, a simple and reliable method by gas chromatograph–mass spectrometry (GC–MS) was developed for the fast and regular identification of 3, 4-MDMA impurities in ecstasy tablets. In so doing, 8 samples of impurities were extracted by diethyl ether under alkaline condition and then analyzed by GC–MS. The results revealed high MDMA levels ranging from 37.6% to 57.7%. The GC-MS method showed that unambiguous identification can be achieved for MDMA from 3, 4-methylenedioxyamphetamine (MDA), Amphetamine (AM), methamphetamine (MA) and ketamine (Keta) compounds, respectively. The experimental results indicated the acceptable time window without interfering peaks. It is found that GC-MS was provided a suitable and rapid identification approach for MDMA (Ecstacy) tablets, particularly in the Forensic labs. Consequently, the intense MDMA levels would support the police to develop a simple quantification of impurity in Ecstasy tablets.en
DOIhttps://doi.org/10.22037/ijpr.2016.1824en
KeywordGas chromatography–Mass Spectrometry (GC–MS)en
KeywordIdentificationen
KeywordDeterminationen
KeywordMDMAen
KeywordIranen
PublisherBrieflandsen
TitleImpact of Pharmaceutical Impurities in Ecstasy Tablets: Gas Chromatography-Mass Spectrometry Studyen
TypeOriginal Articleen

Files